• The Cost Burden of Monoclonal Antibody Therapy In An Athens Greece Tertiary Hospital. A Seven Year Cost Comparison Analysis

    Nov 1, 2015, 00:00

  • Identifying Research Gaps in Antimicrobial Resistance (Amr)- Literature Review, Potential Research Questions and Study Designs

    Nov 1, 2015, 00:00

  • Changes In The Prices Of Reference Biotechnology Products By The Penetration Of Biosimilars Into The Turkish Pharmaceutical Market

    Nov 1, 2015, 00:00

  • Anchoring Bias in Tto Valuations

    Nov 1, 2015, 00:00

  • Estimation of Indirect (Work-Related Productivity) Costs Associated With Moderate-To-Severe Plaque Psoriasis In Germany

    Nov 1, 2015, 00:00

  • Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • The Use Of Real World Evidence To Support Market Access Of Medical Devices – Implications For The German Setting

    Nov 1, 2015, 00:00

  • Physical Functioning and Pain in Chronic Low Back Pain- a Systematic Review of Psychometric Properties of Various Outcomes Measures

    Nov 1, 2015, 00:00

  • O Processo de Contratualização do Hospital Universitário da Ufjf no Contexto do Sus

    Nov 1, 2015, 00:00

  • Implante de Ahmed Versus Implante de Baerveldt- Una Revisión Sistemática y Meta-Análisis

    Nov 1, 2015, 00:00

  • Does A New Pharmacoeconomic Model Is Demanded for Obesity’s Pharmacotherapy Assessment?

    Nov 1, 2015, 00:00

  • Prevalence and Incidence Estimations in German amnog Applications – The Role of Real-World Evidence (RWE)

    Nov 1, 2015, 00:00

  • How Can We Improve The Design Of Patient Preference Research In Oncology? A Case Study In Metastatic Castrate Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Patient Utility Estimates In Patients At High Cardiovascular Risk

    Nov 1, 2015, 00:00

  • Health-Related Quality Of Life In Heart Failure Patients- Health Utilities And Predictive Determinants

    Nov 1, 2015, 00:00

  • Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial- Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36

    Nov 1, 2015, 00:00

  • Type II Diabetes Complications’ Cost in Estonia

    Nov 1, 2015, 00:00

  • Evolution Of Tiotropium Efficacy Vs. Placebo Over Time For The Maintenance Therapy Of Chronic Obstructive Pulmonary Disease- From Investigational Product To Active Reference

    Nov 1, 2015, 00:00

  • Use of Quality of Care (Qoc) Metrics Among Oncologists In the United States (Us)

    Nov 1, 2015, 00:00

  • Early Economic Evaluation of Short-Term Variability of Qt Intervals As A Potential Test for Predicting The Effectiveness of Icd Implantation In Patients With Heart Failure

    Nov 1, 2015, 00:00

  • Evaluación Económica Completa Del Escáner Cervical Avanzado Como Agente Diagnóstico En Pacientes Mexicanas Con Riesgo Asociado A Cáncer De Cérvix Por Vph En México

    Nov 1, 2015, 00:00

  • Symptoms, Concomitant Conditions And Cardiac Risk In European Hydroxyurea Treated Polycythemia Vera Patients

    Nov 1, 2015, 00:00

  • Development Of A Web-Based Quality Of Life Portal For Breast Cancer Patients

    Nov 1, 2015, 00:00

  • The Dutch Melanoma Treatment Registry As Blueprint For Using Registry Data To Improve Health Care Decision Making

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Topical Filed Treatment Therapies for The Treatment of Actinic Keratosis In Greece

    Nov 1, 2015, 00:00

  • Assesing The Net Fiscal Consequences Of Tobacco Use In A High Consumption And High Tobacco Tax Country- The Case Of Greece

    Nov 1, 2015, 00:00

  • A Systematic Review of Economic Evaluations in Latin America- Assessing the Factors that affect Adaptation and Transferability of Results

    Nov 1, 2015, 00:00

  • Propensity Score Matching Does not Always Remove Confounding within an Economic Evaluation Based on a Non-Randomized Study

    Nov 1, 2015, 00:00

  • Willingness to Pay for Innovative Drugs- Anti-Hcv Treatment from the Italian National Health System Perspective

    Nov 1, 2015, 00:00

  • The Economic Burden Of Cardiac Complications Of Percutaneous Coronary Intervention In England- An Analysis Of Hospital Episode Statistics

    Nov 1, 2015, 00:00

  • Cost-Minimisation Analysis of Dexmedetomidine Versus Propofol in Mechanical Ventilated Patients at Icu

    Nov 1, 2015, 00:00

  • Pharmacy Information System In Saudi Hospitals- How Far Is It To Meet Pharmacy Benefit Management Program Requierments?

    Nov 1, 2015, 00:00

  • Cross-Sectional Survey Study to Understand Behaviours, Thoughts and Perceptions of Mealtime Insulin Usage In Patients With Type 1 and Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Efeitos da Atenção Farmacêutica nos Resultados em Saúde Dos Pacientes- Revisão Sistemática Com Meta-Análises

    Nov 1, 2015, 00:00

  • Trends in Hospital Standardized Mortality Ratios in Japan

    Nov 1, 2015, 00:00

  • Health Utilities Associated with Hypoglycemic Events in Type 2 Diabetes Mellitus (T2DM) Patients Receiving Basal-Bolus Insulin Therapy

    Nov 1, 2015, 00:00

  • Economic Evaluation of Ertapenem in the Treatment of Intra-Abdominal Infections, from the Perspective of Imss

    Nov 1, 2015, 00:00

  • Analysis Of In-Hospital Resource Use After An Ischemic Stroke

    Nov 1, 2015, 00:00

  • Cost Benefits Of Incorporating Levosimendan Into Cardiac Surgery Practi German Base Case

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Health State Utility Values In Patients With Migraine

    Nov 1, 2015, 00:00

  • Resource Use and Cost of Chemotherapeutic Treatment for Metastatic Breast Cancer in the Netherlands

    Nov 1, 2015, 00:00

  • The Conceptual Framework and Content Validity of the Polycystic Ovary Syndrome Patient Reported Outcome (Pcos-Pro) Scale

    Nov 1, 2015, 00:00

  • Development Of Medical And Technological Documents On Standardization Of Medical Care In Cardiovascular Diseases In Ukraine

    Nov 1, 2015, 00:00

  • The Evolving Landscape of Early Access Programmes- Comparisons and Implications for Market Access

    Nov 1, 2015, 00:00

  • Healthcare Pathways and Burden of Disease of Patients with Skin and Soft Tissue Infections (Sstis)

    Nov 1, 2015, 00:00

  • High Therapeutic Efficiency With Ledipasvir/Sofosbuvir For The Treatment Of Genotype 1 Chronic Hepatitis C In Portugal

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Respiratory Medication Therapy Adherence Clinic (Rmtac) On Asthma Patients In Malaysia

    Nov 1, 2015, 00:00

  • Quality Of Life And Perspectives Of Happiness In Middle-Aged And Older People With Dysphagia

    Nov 1, 2015, 00:00

  • The International Development of The Modified Hyperphagia Questionnaire

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of Aspirin In The Primary Prevention Of Cardiovascular Diseases And Colorectal Cancer

    Nov 1, 2015, 00:00

  • Comparison of Pharmaceutical Pricing and Reimbursement Systems In Turkey And Certain Other Eu Countries

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Bedaquiline for Patients With Multi-Drug Resistant Tuberculosis in South Korea

    Nov 1, 2015, 00:00

  • Costos Unitarios de Servicios Brindados Por Una Unidad de Salud de la Familia- Evidencia en el Caso Paraguayo

    Nov 1, 2015, 00:00

  • Economic Burden Outcomes In Studies Published In 2014- Which Disease Areas Have Been The Main Focus Of Clinical Research?

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of The Use of Daclatasvir for The Treatment of Hepatitis C Virus (Hcv) Genotypes 3, In The Italian Setting

    Nov 1, 2015, 00:00

  • Determinants of Women’s Choice of Place of Intrapartum Care In Uganda- An Analysis of Secondary Data From Udhs

    Nov 1, 2015, 00:00

  • Systematic Review Of Adherence To Oncological Treatments

    Nov 1, 2015, 00:00

  • Psychometric Validation of the Multidimensional Dyspnea Profile (Mdp) Questionnaire

    Nov 1, 2015, 00:00

  • Cost of Drug-Related Monitoring Requirements for Glatiramer Acetate and Other Multiple Sclerosis Disease-Modifying Therapies (Dmts)

    Nov 1, 2015, 00:00

  • Proposal for A Regulatory Framework for Health Apps to Ensure A Patient Centered Competition Between Providers

    Nov 1, 2015, 00:00

  • The NHS Expenditure Managing Severe Hypoglycemia Episodes in Type 2 Diabetic Patients in Portugal

    Nov 1, 2015, 00:00

  • Physicians’ Choice As A Comparator In Clinical Trials- Challenges for Pharmacoeconomic Modelling of Innovative Treatments to Support Health Technology Assessments

    Nov 1, 2015, 00:00

  • Cost Saving Associated With Glucose Meter Accuraccy In Spain

    Nov 1, 2015, 00:00

  • Longitudinal Modeling The Effect Of Lisdexamfetamine Dimesylate And Changes In Binge Eating Frequency On Disability In Patients With Binge Eating Disorder

    Nov 1, 2015, 00:00

  • Generating Costing Algorithms For Oncology Drugs Using Administrative Databases

    Nov 1, 2015, 00:00

  • Associated Factors The Virologic Success In A Group of Patients With Human Immunodeficiency Virus, Managed By A Care Team Integral, Eps|Sura Medellin 2010-2013

    Nov 1, 2015, 00:00

  • Developing Bilingual Certificate Programs in Clinical Pharmacy

    Nov 1, 2015, 00:00

  • The Willingness Of Cancer Outpatients To Complete Patient-Reported Outcome Measures Outside Of The Clinic

    Nov 1, 2015, 00:00

  • Understanding Patients’ Socio-Economic Burden in Rheumatic Diseases

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation of Geriatric Diabetics in a Tertiary Care Hospital- A Prospective Study

    Nov 1, 2015, 00:00

  • Influence of Patient-Reported Outcomes (Pro) on Market Access Decisions In Markets With Centralized Healthcare Systems

    Nov 1, 2015, 00:00

  • The Use of Single-Arm Evidence In The Comparative Efficacy of Interferon-Free Antivirals for Treatment-Naïve Hepatitis C Genotype 1

    Nov 1, 2015, 00:00

  • Caracterización de Pacientes Con Enfermedad Osteoarticular Desde La Perspectiva Del Aseguramiento en Colombia

    Nov 1, 2015, 00:00

  • The Irish Cost-Effectiveness Threshold- Does It Support Rational Rationing or Might It Lead to Unintended Harm of Ireland’s Health System?

    Nov 1, 2015, 00:00

  • Outpatient Utilization and Quality Appraisal of Antibiotics in Turkey

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Palivizumab In Premature Infants And Children With Chronic Lung Disease In Mexico

    Nov 1, 2015, 00:00

  • Changes In Glucose Lowering Drug Use Before And After A Cancer Diagnosis Among Individuals With Diabetes

    Nov 1, 2015, 00:00

  • Comparação De Custos E Efetividade Entre Ml- Flow E Baciloscopia Para Auxílio Diagn”Stico E Tratamento Da Hanseníase

    Nov 1, 2015, 00:00

  • Risk Of Pneumonia Associated With The Use Of Ics/Laba- A Retrospective Cohort Study In Korea

    Nov 1, 2015, 00:00

  • Costo-Efectividad Del Desfibrilador Externo Automático (Dea) Comparado Con Reanimación Cardiopulmonar Básica (Rcp) En Colombia

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of The Use of Tenecteplase In The Treatment of Acute Myocardial Infarction In Mexico

    Nov 1, 2015, 00:00

  • Reducing The Barriers To Capturing Patient Reported Outcomes In Oncology Studies

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Mirabegron Versus Antimuscarinic Treatments In Patients With Overactive Bladder From The Pespective Of The Spanish National Health Service

    Nov 1, 2015, 00:00

  • Biosimilars- Accessing the Uk Market

    Nov 1, 2015, 00:00

  • Non-Comparative Trials To Supplement Network Meta-Analyses Using Arm-Specific Meta-Regression- An Application To Combination Therapies In Hiv

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of A Genomic Test Compared To Standard Of Care In Breast Cancer Patients In France

    Nov 1, 2015, 00:00

  • A Literature Review To Evaluate The Pharmacoeconomic Value Of Ranolazine For The Treatment Of Symptomatic Chronic Stable Angina

    Nov 1, 2015, 00:00

  • A Decision Options Approach to Antibiotic RD Investment

    Nov 1, 2015, 00:00

  • Cost Comparison of Oral Versus iv Vinorlbine in France in Advanced Breast Cancer

    Nov 1, 2015, 00:00

  • Measuring Post-Partum Hemorrhage In Low-Resource Settings- The Diagnostic Validity Of Weighted Blood Loss Versus Quantitative Changes In Hemoglobin

    Nov 1, 2015, 00:00

  • Modeling The Burden of Abdominal Aortic Aneurysm (Aaa) In Europe In 2013

    Nov 1, 2015, 00:00

  • condition Specific Utilities- Impact on Icer in a Markov Model for Multiple Sclerosis

    Nov 1, 2015, 00:00

  • The Effect of Positioning The Lower Extremities on Postoperative Bleeding After Total Knee Replacement

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of A Novel Pharmacist Guided Warfarin Pharmacogenetic Service

    Nov 1, 2015, 00:00

  • Health State Utilities Associated With Glucose Monitoring Devices

    Nov 1, 2015, 00:00

  • Prevalence Of Chronic Kidney Disease In India- A Systematic Review And Meta-Analysis Of Observational Studies

    Nov 1, 2015, 00:00

  • The Role of Education In The Management of Type 1 Diabetes Mellitus In England

    Nov 1, 2015, 00:00

  • The Relationship Between Socioeconomic Characteristics And Self-Rated Health In Greece

    Nov 1, 2015, 00:00

  • Biossimilars, Are they Really Cost Saving? The Case of Recombinant Human Follicle Stimulating Hormone in Portugal

    Nov 1, 2015, 00:00

  • Steering vaccines through the uk system - what factors influence the likelihood of positive and negative recommendations?

    Nov 1, 2015, 00:00

  • The Use of Real World Data to Build Economic Models- A Case Study of Osteoporosis

    Nov 1, 2015, 00:00

  • To Study The Clinical Characteristics, Treatment Pattern And Factors Associated With The Total Hospital Cost In Acute Respiratory Distress Syndrome In Tertiary Care Hospital

    Nov 1, 2015, 00:00

  • Decrease of Patient Costs in the Netherlands- a Cost of Illness Study in Metastatic Non Small Cell Lung Cancer (Nsclc)

    Nov 1, 2015, 00:00

  • Insurance Plan Switch Patterns Among Breast Cancer Patients Compared to Non-Cancer Patients

    Nov 1, 2015, 00:00

  • Uso de recursos y costos relacionados al tratamiento de complicaciones de la diabetes mellitus tipo 2 (dmt2) en colombia. Una estimacion basada en guias de practica clinica (gpc)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Umeclidinium/Vilanterol In Symptomatic Copd Spanish Patients

    Nov 1, 2015, 00:00

  • Mental Health Disorder Prevalence Trends In Germany- A Longitudinal Analysis

    Nov 1, 2015, 00:00

  • Reference Pricing For Laboratory Tests In The United States- Impact On Prices And Spending

    Nov 1, 2015, 00:00

  • Cost and Cost-Effectiveness Data on Pancreatic Cancer- a Comprehensive Review of the Literature

    Nov 1, 2015, 00:00

  • Machine Learning For Identifying Potentially Undiagnosed Post-Stroke Spasticity Patients In United Kingdom

    Nov 1, 2015, 00:00

  • Can Advances in Health Monitors Lead to Health Being Looked at as A Commodity?

    Nov 1, 2015, 00:00

  • Mortality In A University Pediatric Hospital In Colombia 2000 – 2014

    Nov 1, 2015, 00:00

  • Reliability of Manufacturers’ Budget Impact Estimates for Chronic Hcv Gt1 Drugs in Poland

    Nov 1, 2015, 00:00

  • Comparative Efficacy And Costs Of Treatment Sequences In Metastatic Castration Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Meta-Analysis to Support Technology Submissions to Health Technology Assessment Authorities- Criticisms By Nice And Evidence Review Groups in the Uk

    Nov 1, 2015, 00:00

  • French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours- Perspective For Future Trends

    Nov 1, 2015, 00:00

  • Association Between Depression And Discontinuation With Antidiabetic Drugs

    Nov 1, 2015, 00:00

  • Relationship Between Non Compliance to Claim Medication in Pharmacy and Incidence of Hospitalizations in Patients with Breast Cancer

    Nov 1, 2015, 00:00

  • Using Machine Learning Techniques To Classify Oecd Countries According to Health Expenditures

    Nov 1, 2015, 00:00

  • Survival And Cost Among Photodynamic Therapy Patients With Non-Small Cell Lung Cancer

    Nov 1, 2015, 00:00

  • Direct Cost and Medication Usage Among Insured Type 2 Diabetes Patients with Chronic Kidney Disease under Hospitalization in Beijing and Tianjin, China

    Nov 1, 2015, 00:00

  • Longitudinal Changes in Medical Services Costs from 2006 to 2012 for Newly Diagnosed T2D Patients

    Nov 1, 2015, 00:00

  • Using Real-World Hospital Purchasing And Consumption Data To Improve Healthcare Systems Efficiencies

    Nov 1, 2015, 00:00

  • Cytogenetics And Dopamine Receptor (Drd2) Gene Polymorphism In Schizophrenia Patients

    Nov 1, 2015, 00:00

  • International Differences in the Role of Payer and Administrative Controls in Prescribing Decisions

    Nov 1, 2015, 00:00

  • Preference Elicitation On Benefits And Risks Of Medicines Using A Discrete Choice Experiment

    Nov 1, 2015, 00:00

  • Lipid Modifying Therapy Treatment Patterns And Cholesterol Control After Cardiovascular Events In The United Kingdom

    Nov 1, 2015, 00:00

  • Medical Care And Costs of Patients With Systemic Lupus Erythematosus In Taiwan

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Long-Acting Insulin Analogues in the Perspective of Brazilian Public Health System

    Nov 1, 2015, 00:00

  • Switching to A 6-Monthly Triptorelin Formulation for Prostate Cancer (Pca) Reduces Patient–Nhs Interactions and Hospital Resource use- Real World Evidence (Rwe) from Project Deserve (Decapeptyl Service Evaluation)

    Nov 1, 2015, 00:00

  • Healthcare Pathways And Burden of Disease of Patients With Inflammatory Bowel Diseases (Ibd)

    Nov 1, 2015, 00:00

  • Long-Term Cost-Effectiveness of Transanal Irrigation In Patients With Neurogenic Bowel Dysfunction Who Have Failed Standard Bowel Care

    Nov 1, 2015, 00:00

  • Economic Benefits Of Endometrial Radiofrequency Ablation Compared With Other Endometrial Ablation Techniques In Women With Menorrhagia- A Retrospective Analysis With German Health Claims Data

    Nov 1, 2015, 00:00

  • Usability Testing of an Integrated Glucometer and Handheld Electronic Patient-Reported Outcome System

    Nov 1, 2015, 00:00

  • Accessing The Medical Devices Market In Egypt And Saudi Arabia- A Systematic Review Of Policies And Regulations

    Nov 1, 2015, 00:00

  • Effects Of Lifestyle Interventions On Body Mass Index In Breast Cancer Patients

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Treatment Patients With Craniocerebral Injury In Ukraine

    Nov 1, 2015, 00:00

  • The Association Between Tolerability Issues and Health Outcomes Among Patients with Hcv in Brazil

    Nov 1, 2015, 00:00

  • Proton Pump Inhibitors In Italy- It’s Time to Make A (Policy) Change

    Nov 1, 2015, 00:00

  • New Copd Medicinal Products Entrance Analysis And Their Influence On The Number And Cost Of Hospitalizatons Due To Copd Exacerbations

    Nov 1, 2015, 00:00

  • Conflicts’ Mediation Between Consumers and Health Plans- The Usage Profile of The Available Channels for Complaints

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Novel Oral Anticoagulants for Primary Prevention of Venous Thromboembolic Disease

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Dolutegravir/Abacavir/Lamivudine in Hiv-1 Treatment Naive Patients in France

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Rapid-Acting Analog Insulin for Type 1 Diabetes In The Uk Setting

    Nov 1, 2015, 00:00

  • Implant Versus Oral Contraception Use- 3-Years Budget Impact Analysis for the National Heal System in Portugal

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants And Warfarin for Stroke Prevention In Atrial Fibrillation In Venezuela

    Nov 1, 2015, 00:00

  • Safety And Insurance Premium Implications For Hospitals Based On Subcutaneous Versus Intravenous Administration Of Oncology / Hematology Therapies- Case Studies With Rituximab (Mabthera) And Trastuzumab (Herceptin)

    Nov 1, 2015, 00:00

  • Medication Adherance and Satisfaction With Treatment In Patients With Diabetes Mellitus Receiving Oral Combination Therapy- Data of A Real-World Study

    Nov 1, 2015, 00:00

  • The Epipen4schools® Survey- Staff Training And Use Of Epinephrine Auto-Injectors For The Treatment Of Anaphylaxis In Large Us School Districts

    Nov 1, 2015, 00:00

  • Burden Of Symptomatic Copd Patients In Spain- Data From Continuing To Confront Copd International Patient Survey 2012-2013

    Nov 1, 2015, 00:00

  • Systematic Review And Meta-Analysis of Efficacy And Safety of Simeprevir And Sofosbuvir For Hcv Genotype 1 Infection

    Nov 1, 2015, 00:00

  • Economic Evaluation For The Rapid Test Dpp® Hiv-Syphilis Assay With Immunochromatography In Pregnant Women In Mexico

    Nov 1, 2015, 00:00

  • Does use of calcium channel blockers affect the risk of incident active tuberculosis disease? A nested case control study on a national health claim database

    Nov 1, 2015, 00:00

  • Role Of Budget Impact Analysis In Market Access Of Biosimilars

    Nov 1, 2015, 00:00

  • A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis- Compliant Vs. Non-Compliant Patients

    Nov 1, 2015, 00:00

  • The Research on The Relationship Between The Ovarian Function Damage With Fluorosis and The Protective Effect of Selenium

    Nov 1, 2015, 00:00

  • Resource And Cost Savings Due To Subcutaneous Versus Intravenous Administration Of Oncology Therapies- Case Studies With Rituximab (Mabthera) And Trastuzumab (Herceptin)

    Nov 1, 2015, 00:00

  • Delay Of Optimal Nocturia Treatment Is Costly- Results Of A Real World Survey Of Patients In Europe And The Usa

    Nov 1, 2015, 00:00

  • Search for Clinically and Economically Effective Lymphomas Treatment

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Uso De Rivaroxabán Como Profilaxis En Cirugía De Reemplazo Total De Cadera Y/O De Rodilla Frente A Enoxaparina, En Colombia

    Nov 1, 2015, 00:00

  • Vedolizumab In Crohn’s Disease; A Budget Impact Model for A Novel Drug In A Recession Environment

    Nov 1, 2015, 00:00

  • Evaluacion De Costo-Utilidad Del Uso De Cetuximab Como Última Línea De Tratamiento Del Cáncer Colorrectal Metastásico

    Nov 1, 2015, 00:00

  • Analysis of The Cost of Invasive Fungal Infections In Patients With Hemopoetic Stem Cell Transplantation

    Nov 1, 2015, 00:00

  • Cost utility analysis of spinal cord stimulation vs. Reoperation in the treatment of failed back surgery syndrome in colombia

    Nov 1, 2015, 00:00

  • The german nice or the german nasty? an analysis of iqwig decisions and requirements for an ‘added benefit'

    Nov 1, 2015, 00:00

  • Experiences With Price Competition Of Biosimilar Drugs In Hungary In Case Of Erythropoietin Products

    Nov 1, 2015, 00:00

  • Healthcare Costs Associated With Non-Valvular Atrial Fibrillation In Italy

    Nov 1, 2015, 00:00

  • Decision Drivers in Health Technology Assessment in Hepatitis C

    Nov 1, 2015, 00:00

  • Increased Costs Due To Myocardial Infarction (Mi) In Fran An Observational Analysis Using A Claims Database

    Nov 1, 2015, 00:00

  • Costs of Relapse of Schizophrenia for Colombian Health System

    Nov 1, 2015, 00:00

  • The Most Profitable Health Insurance “Company” In Turkey

    Nov 1, 2015, 00:00

  • Regulations of The German Drug Market

    Nov 1, 2015, 00:00

  • The Indirect Costs of Types 1 Diabetes Mellitus Associated with Absenteeism in Poland in 2013

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Pramipexole Extended Release Monotherapy In Early Parkinson’S Disease

    Nov 1, 2015, 00:00

  • Qualitative Equivalence Between Paper and Ediary Versions and Usability of 4 Pro Questionnaires for Uterine Fibroids

    Nov 1, 2015, 00:00

  • Inflation, Inflexibility and Irrelevance – the Need for Inflation to be Accounted for in Icer Thresholds

    Nov 1, 2015, 00:00

  • La Canasta Basica de Medicamentos Como Estrategia Para Mejorar el Acceso y Costo de Los Medicamentos en Panama

    Nov 1, 2015, 00:00

  • Resource Utilization And Treatment Costs Of Stroke In Patients With Non-Valvular Atrial Fibrillation In Spain

    Nov 1, 2015, 00:00

  • Medical Devices For Bandaging And Plasters. Cost And Quantity Characteristics In Slovakia 2009 - 2013

    Nov 1, 2015, 00:00

  • Comparison of Cost of Treatment of Selected Cancers with Patented Drugs- India Versus its Neighbors

    Nov 1, 2015, 00:00

  • Current Challenges and Opportunities to Market Access in Brazil, Argentina, Mexico and Colombia

    Nov 1, 2015, 00:00

  • Review Of The Current Status Of Ras Mutation Testing In Patients With Metastatic Colorectal Cancer (Mcrc)- Flash-Ras Study

    Nov 1, 2015, 00:00

  • Sq® Hdm Slit-Tablets In Addition To Pharmacotherapy Are Cost-Effective Compared To Pharmacotherapy Only In Treating Patients With Allergic Asthma

    Nov 1, 2015, 00:00

  • Ankylosing Spondylitis Treatment and Follow-Up Costs in Colombia

    Nov 1, 2015, 00:00

  • Patterns of Utilization and Cost of Prostacylins for Pulmonary Arterial Hypertension

    Nov 1, 2015, 00:00

  • Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England- Comparison of A Markov and Discrete Event Simulation Model

    Nov 1, 2015, 00:00

  • Tioropium+Olodaterol Respimat; Budget Impact In The Uk

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Cetuximab In First-Line Treatment Of Patients With Metastatic Colorectal Cancer In Belgium And The Netherlands

    Nov 1, 2015, 00:00

  • Which Risk Share Agreements are Available and are Those Applied In Global Reimbursement Decisions?

    Nov 1, 2015, 00:00

  • Experts Consensus on The Future of Rare Diseases Care and Orphan Drugs Access In Spain- A Delphi Study

    Nov 1, 2015, 00:00

  • The Impact of Anti-Tnf (Etanercept) Therapy on Work Productivity in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in the Czech Republic

    Nov 1, 2015, 00:00

  • Risk Factors and Causes of Intrauterine Death

    Nov 1, 2015, 00:00

  • Network Meta-Analysis On Prevention Of Stroke For Patent Foramen Ovale Closure

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Diabetic Macular Edema (Dme) In Turkey- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • Access to Biologics for Rheumatoid Arthritis in the Public Sector of a Latam Country

    Nov 1, 2015, 00:00

  • There Is Evidence of Increased Risk of Cancer In Patients Using Human Insulin Analogue Glargine For Treatment of Diabetes Mellitus - Overview Based Evaluation

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Insulin Analogues Compared with Multiple Daily Injections of Human Insulin for the Treatment of 15 Years Old or Older Patients with Type 1 Diabetes Mellitus in Colombia

    Nov 1, 2015, 00:00

  • Indirect Treatment Comparison (Itc) To Demonstrate The Utility Of Oncolitbank- An Oncology Literature Registry

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of 18 Month Booster Dose of A Pertussis-Containing Vaccine on The Australian National Immunisation Program- A Dynamic Model-Based Analysis

    Nov 1, 2015, 00:00

  • Cost-minimization analysis of the carboxymaltose ferric (i.v.) Compared with sacarato ferric (i.v.) in the treatment of anemia under suplementary health care perspective

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Ferric Carboxymaltose in Patients with Colon Cancer and Anemia

    Nov 1, 2015, 00:00

  • Management Of Sore Throat In Community Pharmacy In Fran A National Observational Study

    Nov 1, 2015, 00:00

  • The Life Time Cost-of-Disease (Cod) of Metastatic Colorectal Cancer (Mcrc) in Turkey- an Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • Indirect Comparison to Evaluate the Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors (DPP4I) and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2I) Added to Insulin Therapy in Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Management of Statin Intolerance (Si) in Patients at High Risk for Cardiovascular (Cv) Events- Results of a Canadian Study

    Nov 1, 2015, 00:00

  • Intermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers- Patterns of Treatment and Costs

    Nov 1, 2015, 00:00

  • Representing the Threshold in the Cost-Effectiveness Plane- Proposing a New Graphical Convention

    Nov 1, 2015, 00:00

  • Análisis De Costo Efectividad Del Uso De Sorafenib En Pacientes Con Carcinoma Hepatocelular En Estadios Avanzados, Para El Contexto Ecuatoriano

    Nov 1, 2015, 00:00

  • Finding The Optimal Screening Program For Unknown Atrial Fibrillation Using Simulation Models

    Nov 1, 2015, 00:00

  • Productivity Loss Costs Attributable to Obesity in Working Patients with Diabetes in the US

    Nov 1, 2015, 00:00

  • Tratamiento Ambulatorio Versus Hospitalario Relacionado A Agudizaciones En Pacientes Con Asma Desde Una Perspectiva Institucional Publica Mexicana

    Nov 1, 2015, 00:00

  • Systematic Literature Review And Critical Appraisal Of The Suitability Of The Outcome Measures Used In The Idiopathic Pulmonary Fibrosis

    Nov 1, 2015, 00:00

  • Differences And Similarities In Hta- A Comparative Analysis Of The Decision-Making Processes For Cancer Drugs Across 4 Countries

    Nov 1, 2015, 00:00

  • Does Out-Patient Medical Insurance Policy Work Among Ckd Patients In Non-Dialysis Phases? Evidence From Two Sample Cities In China

    Nov 1, 2015, 00:00

  • An Evaluation of a New Regional Decision making Process in Sweden for High-Cost Hospital Therapies

    Nov 1, 2015, 00:00

  • An Open Label, One Arm Study To Evaluate The Efficacy And Safety of Cerebrolysin In Patients With Acute Severe Ischemic Stroke In Mexico

    Nov 1, 2015, 00:00

  • National Estimates of Prevalence and Patterns of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson’s Disease in Nursing Home and Home Healthcare Settings in the United States

    Nov 1, 2015, 00:00

  • Characterization of Osteoporosis In Portugal - Treatment Patterns And Reasons for Under-Treatment and Non-Persistence With Pharmacological Treatments

    Nov 1, 2015, 00:00

  • Antipsychotic Exposure And Risk of Stroke- A Systematic Review And Meta-Analysis of Observational Studies

    Nov 1, 2015, 00:00

  • Análise De Custo-Utilidade Em Pacientes Com Insuficiência Renal Crônica Submetidos À Terapia Renal Substitutiva (Trs)

    Nov 1, 2015, 00:00

  • The End of the Exceptional Financing of Erythropoiesis-Stimulating Agents in French Hospitals- What are the Impacts For Public Hospitals of Paris ?

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy

    Nov 1, 2015, 00:00

  • A Comparison Of Two Low-Molecular-Weight Heparins (Lmwhs) In Terms Of Cost Per Patient

    Nov 1, 2015, 00:00

  • Cost Analysis in Implementing Rituximab for non-Hodgkins Lymphoma - Intravenously and Subcutaneously - in Patients with Social Coverage in Latam

    Nov 1, 2015, 00:00

  • Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) – First Step Towards a Pro Measure in Lpld

    Nov 1, 2015, 00:00

  • Systematic Review Of Productivity Losses Associated With Cardiovascular Disease In Europe

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Oral Chemotherapy Regimen In Metastatic Breast Cancer Egyption Prospective

    Nov 1, 2015, 00:00

  • Evaluaci”N De Costo-Efectividad De La Implementaci”N De Monitoreo Ambulatorio De Presi”N Arterial Versus Perfil De Presi”N Arterial Para El Diagn”Stico De Hipertensi”N En El Sistema Público Chileno

    Nov 1, 2015, 00:00

  • Prevalence of Self-Medication and Its Reason Among Pharmacy Students in India- A cross-sectional study

    Nov 1, 2015, 00:00

  • Societal and Non-Healthcare Costs Associated With Atypical Haemolytic Uraemic Syndrome In The Uk- Results of A Patient Survey

    Nov 1, 2015, 00:00

  • Aumento del Riesgo de Cancer por Efecto de Variaciones Acumuladas en la Exposici”n a la Radiacion en Estudios de Radiología Convencional y Tomografía Computarizada en Pacientes Pediátricos

    Nov 1, 2015, 00:00

  • Construction Of Simulation Techniques For Development Of Optimal Cervical Cancer Screening Strategies- Experience Of Ukraine

    Nov 1, 2015, 00:00

  • Contraception Patterns In Fran A Real-World Database Analysis

    Nov 1, 2015, 00:00

  • Long-Term Increased Inpatient and Outpatient Visits Associated with Cardiovascular Events- a Large United States Real World Study

    Nov 1, 2015, 00:00

  • Health-Related Quality Of Life In Bladder Cancer- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Neoplasm of Colon

    Nov 1, 2015, 00:00

  • Comparative Analysis of The Reimbursement Landscape of Orphan Drugs on An International Level

    Nov 1, 2015, 00:00

  • The Impact Of Pharmaceutical Innovation On Longevity In Portugal, 2002–2010

    Nov 1, 2015, 00:00

  • Economic and Humanistic Burden of Ductal Carcinoma in Situ

    Nov 1, 2015, 00:00

  • Migration of the Fatigue Symptoms and Impacts Questionnaire–Relapsing Multiple Sclerosis (Fsiq-Rmstm) from Paper to an Electronic Diary Format

    Nov 1, 2015, 00:00

  • Association between Weight Change, Diabetes-Related Healthcare Costs, and HbA1c among Patients with Type 2 Diabetes

    Nov 1, 2015, 00:00

  • The Analysis of Telemedicine Technologies In Pediatric Patients

    Nov 1, 2015, 00:00

  • Confirmed Disability Improvement In Patients With Active Multiple Sclerosis Treated With Fingolimod Versus Bra A Matched Comparison of Treatments From The Pangaea And Pearl Registry Studies

    Nov 1, 2015, 00:00

  • Reduction of Complications and Associated Costs for Type 2 Diabetic Patients Using Continuous Subcutaneous Insulin Infusion In The Uk

    Nov 1, 2015, 00:00

  • A Pitcure of Private Health Insurance Policyholders in Italy

    Nov 1, 2015, 00:00

  • Barriers To Participation In Trials Of Cancer- A Survey On Clinical Research Perception

    Nov 1, 2015, 00:00

  • Determinant Factors of the Administrative Pathway to Access Medicines in the Brazilian Health System

    Nov 1, 2015, 00:00

  • Network Meta-Analysis for Health Technology Submissions Worldwide- A Report Checklist for Network Meta Analysis Best Practices Globally

    Nov 1, 2015, 00:00

  • Quality Of Life In Patients With Kidney Cancer In Slovakia

    Nov 1, 2015, 00:00

  • Prices of Pharmaceuticals Under a Generic Price Linkage System And a Reference Price System- Comparison of Austria and Finland

    Nov 1, 2015, 00:00

  • Cost-Utility of Bariatric Surgery In Belgium, Denmark, and Italy

    Nov 1, 2015, 00:00

  • Impacto Orçamentário do Everolimo e Sirolimo para Imunossupressão em Transplantados Hepáticos no Sistema Público de Saúde do Brasil

    Nov 1, 2015, 00:00

  • Patient Reported Outcome in Health Services Research- A Prospective Study of Orthopedic Surgery in Routine Care in Switzerland

    Nov 1, 2015, 00:00

  • Hospital Readmissions and Mortality Patterns in a Cohort with Heart Failure- 1 Year Follow-Up from the Brazilian Public Healthcare System Database

    Nov 1, 2015, 00:00

  • Utilizacion De Antibacterianos De Uso Restringido En Pacientes Adultos Hospitalizados En El Hospital Las Higueras - Talcahuano

    Nov 1, 2015, 00:00

  • A Systematic Literature Review On The Impact Of Therapeutic Interventions On Quality Of Life In Systolic Hf Randomized Clinical Trials

    Nov 1, 2015, 00:00

  • Similarities and Differences In Orphan Drug Reimbursement In 16 European Countries

    Nov 1, 2015, 00:00

  • Characteristics and Healthcare Resource use of Patients with Major Depressive Disorder Initiated on Snri Compared to Ssri In Beijing China

    Nov 1, 2015, 00:00

  • Cost Implications of Further Limiting or Increasing Generic Prescribing of Antiepileptics In English And Welsh General Practices

    Nov 1, 2015, 00:00

  • Assessing the Translatability of the Term “Distressed”

    Nov 1, 2015, 00:00

  • Building a Bridge Between Clinical Evidence Research and Patient Preference Research

    Nov 1, 2015, 00:00

  • Estimating Lifetime Medical Costs From Censored Claims Data

    Nov 1, 2015, 00:00

  • Baseline Characteristics of Rheumatoid Arthritis Patients Starting Certolizumab Pegol Therapy And Glucocorticoid Prescription In The Eclair Study In 2012–2013

    Nov 1, 2015, 00:00

  • Modelling The Likely Impact of The Obesity Epidemic on Mortality And Cause of Death In Older Adults

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Central Retinal Vein Occlusion (Crvo) In Turkey- An Expert Panel Approach For Estimation of Costs

    Nov 1, 2015, 00:00

  • Patient Reported Outcomes in the Development of new Medications for Type 2 Diabetes- a Review of Recently Approved Products

    Nov 1, 2015, 00:00

  • Cost-Utility Of Ranolazine For The Symptomatic Treatment Of Patients With Chronic Angina Pectoris In Greece

    Nov 1, 2015, 00:00

  • Descriptive Epidemiology And Treatment Strategies Used In Multiply Myeloma In The Slovak Republic. Results From The Cross-Sectional Survey In The Haematology-Oncological Centers

    Nov 1, 2015, 00:00

  • Measurement Of Hope In Patients With Cancer

    Nov 1, 2015, 00:00

  • Development of A Precis-2 Scoring Grid- How Pragmatic are Pragmatic Trials of Surgical and Pharmaceutical Interventions?

    Nov 1, 2015, 00:00

  • Cost Analysis of Proton Pump Inhibitors In The Treatment of Gastroesophageal Reflux Disease In Ukraine

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Continuous Remote Monitoring Of Heart Failure Patients With Cardiac Electronic Implantable Device

    Nov 1, 2015, 00:00

  • A Systematic Review Of Markov Models Evaluating Multi-Component Disease Management Programs

    Nov 1, 2015, 00:00

  • Assessment of Hiv-Related Quality of Life in a Representative Sample Of French Patients using Multivariate Multi-Block Statistical Models

    Nov 1, 2015, 00:00

  • Economic Impact of Expanded Use of Biologic Therapy for Crohn’s Disease In Latin American Countries

    Nov 1, 2015, 00:00

  • Progressive Disease Does Not Impact Hrqol In Patients Receiving Nivolumab For The Treatment Of Unresectable Or Metastatic Melanoma

    Nov 1, 2015, 00:00

  • Impacto Orçamentário Do Everolimo, Sirolimo E Tacrolimo Para Imunossupressão Em Transplantados Cardíacos No Sistema Público De Saúde Do Brasil

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management

    Nov 1, 2015, 00:00

  • Impact of Hta – an Irish Case Study

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Intravitreal Aflibercept In Diabetic Macular Oedema In Sweden

    Nov 1, 2015, 00:00

  • Targeted Combination Regimes In Oncology Challenges for Pricing and Reimbursment In Switzerland- Analysis of The Implication and Operational Requirement For Implementation of An Indication Code

    Nov 1, 2015, 00:00

  • An Epidemiological Evaluation Of The Impact Of Percutaneous Coronary Interventions On The Hospitalization Cost, Length Of Stay And Mortality Of Patients Hospitalized With Acute Coronary Syndromes

    Nov 1, 2015, 00:00

  • Evaluación Económica del uso de Un Paquete de Tres Torundas de Algodón Estériles Frente a Toallas Impregnadas Con Solución Antiséptica Como Estrategia de Antisepsia en Venopunción

    Nov 1, 2015, 00:00

  • Increase Arv Access for Plwha In Dominican Republic Through The Transition From Vertical Supply System to An Integrated National Pharmaceutical System

    Nov 1, 2015, 00:00

  • Pro Self-Assessment and Patient Retention in Major Depression Studies- Efficiency of a Direct-To-Patient Contact Approach

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation of the Introduction of Routine Varicella Vaccination in Children in the United Kingdom

    Nov 1, 2015, 00:00

  • Appraising the Value of Lenvatinib for Radio-Iodine Refractory Differentiated Thyroid Cancer (Rr-Dtc)- A Multi-Country Study Applying Holistic Multicriteria Decision Analysis (Mcda)

    Nov 1, 2015, 00:00

  • Medical Costs And Resources Consumption In Patients With Atrial Fibrillation- An Italian Observational Study

    Nov 1, 2015, 00:00

  • Orphan Drugs Assessment in Germany- A Comparison with Other International HTA Agencies

    Nov 1, 2015, 00:00

  • Pattern And Factors Associated With Readmission In Patients Hospitalized For Chronic Obstructive Pulmonary Disease In Taiwan

    Nov 1, 2015, 00:00

  • A Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease in Belgium

    Nov 1, 2015, 00:00

  • Cognitive Symptoms In Major Depressive Disorder And Their Italian Psychiatrists’ Perception

    Nov 1, 2015, 00:00

  • Development Of A Patient-Reported Outcome (Pro) Assessment Of Core Non-Small Cell Lung Cancer (Nsclc) Symptoms

    Nov 1, 2015, 00:00

  • Uptake Of Filgrastim ‘Biosimilars’ In The United States- Analysis Of A Medical Transcription Database Of Patient Office Visits

    Nov 1, 2015, 00:00

  • Patients Experience At Hospital Discharge and Readmissions

    Nov 1, 2015, 00:00

  • Using Decision Making Clinical Scenarios to Appraise Preferences and Value Judgments in Health Technology Assessment (Hta)

    Nov 1, 2015, 00:00

  • Costs of Absenteeism In Ankylosing Spondylitis Based on Real-Life Data From Poland’s Social Insurance Institution Database In 2013

    Nov 1, 2015, 00:00

  • Examination of Water Consumption- Knowledge About Water Consumption In Population of Bátya And Pécs

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Cardio-Desfibrilador Implantable Comparado Con La Terapia Farmacológica Optima Para El Tratamiento De Los Pacientes Con Falla Cardiaca En Colombia

    Nov 1, 2015, 00:00

  • Economic Burden of Type 2 Diabetes Mellitus Treatment Strategies- A Cost Consequence Analysis of Sitagliptin vs Sulfonylureas in Lombardy Region

    Nov 1, 2015, 00:00

  • Envolvimento do Público no Processo de Incorporação de Tecnologias no Sus

    Nov 1, 2015, 00:00

  • The Economic Burden of Brain Disorders In Korea

    Nov 1, 2015, 00:00

  • Are Qalys An Appropriate Measure To Use When Evaluating Public Health Interventions In The Uk?

    Nov 1, 2015, 00:00

  • Irrational Drug Use Pattern In Hospitals. A Warning for Health Care System

    Nov 1, 2015, 00:00

  • Selecting Evidence-Based Preventive Treatment Thresholds By Optimizing Preferred Outcomes

    Nov 1, 2015, 00:00

  • A Cost Effectiveness Analysis of Nivolumab Compared to Ipilimumab for the Treatment of Braf Wild-Type Advanced Melanoma in Australia

    Nov 1, 2015, 00:00

  • Practices of Substance Abuse and Risky Sexual Behavior Among Adama Science and Technology University Undergraduate Students in 2012/13 Academic Years

    Nov 1, 2015, 00:00

  • Clinical and Economic Impact of Chronic Heart Failure in General Practi Analysis of 13.633 Patients

    Nov 1, 2015, 00:00

  • The Economics of the Treatment and Follow-Up of Patients with Glioblastoma

    Nov 1, 2015, 00:00

  • Immunisation in Latin America- Factors Preventing Uptake of Cost-Effective Vaccines

    Nov 1, 2015, 00:00

  • First Real-World Study Assessing Health Utility Values For Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d

    Nov 1, 2015, 00:00

  • Promis® Physical Function Multilingual Translations- Progress And Outlook

    Nov 1, 2015, 00:00

  • A Pragmatic Approach to Data Source Selection for use In Real-World Evidence (Rwe) Generation

    Nov 1, 2015, 00:00

  • Statin Use and Risk of New-Onset Type 2 Diabetes Mellitus and Cardiovascular Disease- a Nationwide Population-Based Observational Study Using National Claim Data

    Nov 1, 2015, 00:00

  • The Rheumatologist’s Perspective In Diagnostic Course and Management of Familial Mediterranean Fever

    Nov 1, 2015, 00:00

  • Recent Update to Russia’s Essential Drugs List and Seven Nosologies- Clinical Differentiation And Local Manufacturing Implications for New Drug Inclusion

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life In Patients With Adrenal Insufficiency Receiving Plenadren Compared With Immediate-Release Hydrocortisone

    Nov 1, 2015, 00:00

  • Cost-Effectivness Analysis of Shizophrenia Treatment With Haloperidol , Olanzapine And Risperidone In Bosnia and Hercegovina ,Republic of Srpska By Application of The Markov Model

    Nov 1, 2015, 00:00

  • An Analysis Of Drivers Of Positive And Negative Appraisals By Nice’s Medical Technology Evaluation Programme (Mtep)

    Nov 1, 2015, 00:00

  • Estimating The Economic Consequences Of An Increased Medication Compliance Due To A Potential Improvement Of The Inhaler Technique With Spiromax® Compared With Turbuhaler® In Moderate To Severe Patients With Copd In Spain

    Nov 1, 2015, 00:00

  • Additional Cost of Vte In Patients with Cancer- an Approach Based Databases

    Nov 1, 2015, 00:00

  • Drug Pricing Information Management- Development Of A Web Based E-Pricing System

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Uso De Trastuzumab-Emtansine Para El Manejo De Pacientes Con Cáncer De Mama Her2 Positivo Avanzado Con Tratamiento Previo Con Trastuzumab Y Un Taxano Por Separado O En Combinación, Para Venezuela

    Nov 1, 2015, 00:00

  • Current Perception of Upcoming Cost-Effectiveness Requirements in Japan- a Survey on the Perspective of Pharmaceutical Industry

    Nov 1, 2015, 00:00

  • Prediction Of Future Health Insurance Expenditures In Hungary According To Population Forecast Scenarios

    Nov 1, 2015, 00:00

  • Public Health Outcomes of Paediatric Influenza Vaccination With An Intranasal Tetravalent Live Attenuated Vaccine In Belgium Using A Dynamic Transmission Model

    Nov 1, 2015, 00:00

  • Análisis Del Comportamiento De La Drepanocitosis En Colombia, Desde La Perspectiva Del Uso De Servicios De Salud

    Nov 1, 2015, 00:00

  • Patient Heterogeneity In Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (Copd)- are Current Models Suitable to Evaluate Personalized Medicine

    Nov 1, 2015, 00:00

  • The Challenges in Evaluating the Cost-Effectiveness of Complex Interventions

    Nov 1, 2015, 00:00

  • Systematic Review Of Cost Effectiveness Of Gefitinib In The Treatment Of Non-Small Cell Lung Cancer In China

    Nov 1, 2015, 00:00

  • Streamlining The Access Decision Process For German Patients to Receive Reimbursed Treatments In Another European Union Member State

    Nov 1, 2015, 00:00

  • Access to Healthcare Among International Immigrants in Chile- Repeated Cross-Sectional Analysis of Casen Survey 2006-2009-2011

    Nov 1, 2015, 00:00

  • Health Technology Assessment In Chronic Hepatitis C- Assessment of Decision Landscape And Manufacturer Inputs In Six Agencies

    Nov 1, 2015, 00:00

  • Relationship between Spending on Diabetes Drugs and Occurrence of Risks Associated with Type 2 Diabetes in English General Practices

    Nov 1, 2015, 00:00

  • Work Capacity And Health Status Test of Police Officers

    Nov 1, 2015, 00:00

  • The Quality Of Life In Patients 12 Months After An Acute Coronary Syndrom- Results From The Pgrx-3 Real World Dataset

    Nov 1, 2015, 00:00

  • Evaluation of Psoriasis Patients’ Attitude to Risk- Benefit And Therapeutic Tradeoffs In Their Choice of Treatments

    Nov 1, 2015, 00:00

  • Risk Factors for Coronary Artery Disease In Patients With Rheumatoid Arthritis

    Nov 1, 2015, 00:00

  • Economic Evaluations of Treatments for Inflammatory Bowel Diseases

    Nov 1, 2015, 00:00

  • Son útiles los enfoques de separación de funciones y cadena de valor para mejorar la organización, regulación y acceso a medicamentos?

    Nov 1, 2015, 00:00

  • Trends In End-Of-Life Appraisals And Recommendations By Nice For Oncology Therapies

    Nov 1, 2015, 00:00

  • Total Annual Cost Associated with Best Supportive Care of Patients with Unresectable Advanced Non-Small-Cell Lung Cancer Under Real-World-Conditions in Relation to Results of International Studies

    Nov 1, 2015, 00:00

  • Pharmacoeconomical Characteristics of Different Strategies of Hemostasis During Extensive Hepatectomy

    Nov 1, 2015, 00:00

  • Reimbursement of Orphan and Expensive Drugs In The Netherlands- Exploration of Essential Criteria In The Decision Making Process

    Nov 1, 2015, 00:00

  • Qualitative Interviews To Provide In-Depth Understanding Of The Impact Of Non-Small Cell Lung Cancer (Nsclc) And Its Treatment On Of The Lives Of Patients And Their Families/Caregivers

    Nov 1, 2015, 00:00

  • Risk of Fracture in Type 2 Diabetes Mellitus Patients- Meta-Analysis of Observational Studies

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Simeprevir Vs. Telaprevir for The Triple Therapy of Hepatitis C In Kazakhstan

    Nov 1, 2015, 00:00

  • Using Incentives to Improve Health-Related Behaviours- A Review of Incentive-Based Trials

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Romiplostim As First-Line Primary Immune Thrombocytopenia (Itp) Treatment in Adult Splenectomised Patients Who are Refractory to Other Treatments and As Second-Line Itp Treatment in Adult Non-Splenectomised Patients Wh ...

    Nov 1, 2015, 00:00

  • Cost of Paediatric Vaccine Administration in the United Kingdom (UK)- a Time and Motion (TM) Study

    Nov 1, 2015, 00:00

  • Over-Prescription Of Fingolimod In Germany

    Nov 1, 2015, 00:00

  • Predictors of 10-Year Mortality After Primary Femoral Neck Fracture In Elderly Patients

    Nov 1, 2015, 00:00

  • The Consequences Of Replacing The Fleischner Guidelines By A Software-Based Volume Doubling Time Technique- An Early-Stage Research

    Nov 1, 2015, 00:00

  • The 3-Arm Strategy for Readmission Prevention- Automated Predictive Modeling, Readmission Prevention Intervention, and Monitoring

    Nov 1, 2015, 00:00

  • Disease Prevalence and Healthcare Resources Consumption in Patients with Basal Cell Carcinoma in Italian Lhus

    Nov 1, 2015, 00:00

  • Economic Burden and Quality of Life of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Germany- Results From The Ibis-C Study

    Nov 1, 2015, 00:00

  • The Competition Between Drugstore And Primary Care And Treatment Choice Of Patients In The Context Of Essential Medicine Policy In Rural China

    Nov 1, 2015, 00:00

  • Burden of Heart Failure In Latin America- A Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00

  • The Cost and Length of Stay of Hospital Emergency Department Visits for Chronic Heart Failure Patients in Canada

    Nov 1, 2015, 00:00

  • Evaluation of The Effect of Crude Leaves Extract of Indigofera Spicata Forssk.(Fabaceae) on Blood Glucose Level of Normoglycemic, Oral Glucose Loaded and Alloxan Induced Diabetic Rodents

    Nov 1, 2015, 00:00

  • Analysis Of Costs For Diagnosis And Differential Diagnosis Of Patients With Possible Temporomandibular Disorders In Ukrane

    Nov 1, 2015, 00:00

  • Efficacy And Safety Profile Of Combined Targeted Therapy Against Egfr And Vegf In Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer- A Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00

  • Inpatient Burden Among Patients With Cystic Fibrosis Who Are Homozygous for The F508del Mutation

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of Tripliam For The Treatment Of Hypertension In Italy

    Nov 1, 2015, 00:00

  • Effect of Educational Intervention on Osteoporosis Knowledge Among University Female Students in Quetta, Pakistan

    Nov 1, 2015, 00:00

  • The Influence Of The Revision Of The Medical Fee Schedule On National Hospital Organisation Hospitals In Japan

    Nov 1, 2015, 00:00

  • The Association of Waist Circumference and Microvascular Complications in Diabetic Patients in an Asian Population

    Nov 1, 2015, 00:00

  • Evaluation of Inpatients’satisfaction in Pafos General Hospital, Cyprus

    Nov 1, 2015, 00:00

  • Prescription Patterns Of Drugs For Attention-Deficit/Hyperactivity Disorders In Japanese Children And Adolescents

    Nov 1, 2015, 00:00

  • Burden of Disease of Ovarian Cancer in Spain. Ovarcost Study

    Nov 1, 2015, 00:00

  • Reducing Insulin Syringe Reuse Can Help Lower Cost of Insulin Waste In Brazil

    Nov 1, 2015, 00:00

  • How Pricing And Reimbursement Policies Affect The Budget Impact of The Treatment of Systemic Juvenile Idiopathic Arthritis In Turkey

    Nov 1, 2015, 00:00

  • Simeprevir Plus Peginterferon/Ribavirin Cost-Effectiveness Analysis for the Treatment of Chronic Genotype 1 Hepatitis C in Mexico

    Nov 1, 2015, 00:00

  • Intra- And Extra-Organizational Factors Affecting Community Pharmacy Performance

    Nov 1, 2015, 00:00

  • Global Publication Trends in Medical Nutrition Health Economics

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Blood Clotting Factor Concentrates In The Treatment of Von Willebrand Disease

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Plaque Psoriasis In The Italian Setting

    Nov 1, 2015, 00:00

  • Compliance With Allopurinol Among Hypertensive Patients With Gout Diagnosis and The Relationship to Onset of End-Stage Renal Disease

    Nov 1, 2015, 00:00

  • From Phase Ii Studies to Hta Submissions- Optimal Use of Evidence for Informed Decisions

    Nov 1, 2015, 00:00

  • Biologics In Ulcerative Colitis (Uc)- Treatment Guidelines and Health Technology Assessments (Hta)

    Nov 1, 2015, 00:00

  • Comparative Tolerability of New Antipsychotic Drugs in Schizophrenia- A Systematic Review and Meta-Analysis

    Nov 1, 2015, 00:00

  • Quantifying The Impact of Treatment on The Public Health Burden of Adpkd- A Uk Case Study Using The Adpkd Outcomes Model

    Nov 1, 2015, 00:00

  • Monitoring Of Critical Laboratory Results To Improve Quality Of Patient Care In A Large Urban Clinic In Uganda

    Nov 1, 2015, 00:00

  • Students’ Knowledge and Perceptions Towards Quality Use of Medicines- A Descriptive Analysis From Universiti Sains Malaysia

    Nov 1, 2015, 00:00

  • A Discrete Choice Experiment For Engaging Patients In Reimbursement Decision Making- Patient Preferences On Adjuvant Chemotherapy In Breast Cancer

    Nov 1, 2015, 00:00

  • Economic Analysis of Outpatient Parenteral Antimicrobial Therapy (Opat)- A Systematic Review

    Nov 1, 2015, 00:00

  • A Retrospective, Cross Sectional Study on the Prevalence of Hypertension and Treatment Status in Obese Patients Using a Healthcare Database in Japan

    Nov 1, 2015, 00:00

  • Costs Of Compression Therapy In Venous Leg Ulcers In Germany And Modelling Of The Economic Effects Of Regional Disparities In Health Care

    Nov 1, 2015, 00:00

  • Patterns Of Medication Use In Chronic Kidney Disease Stage 5d- Emphasis On Medications For The Management Of Ckd-Mbd

    Nov 1, 2015, 00:00

  • Identification Of Items For A Standardised Resource-Use Measure- Review Of Current Instruments

    Nov 1, 2015, 00:00

  • A Long Term Analysis of The Clinical And Cost Effectiveness of Glatiramer Acetate From The Uk Multiple Sclerosis Risk Sharing Scheme

    Nov 1, 2015, 00:00

  • How to Determine The Target Population In Early Benefit Assessments In Germany? The Case of Diabetes Mellitus Type 2

    Nov 1, 2015, 00:00

  • An Update on Healthcare Resource Use and Economic Burden In Alzheimer’s Disease In The United States (Us) From A Medicare Sample Analysis

    Nov 1, 2015, 00:00

  • A Cost-Effective Enhanced Retrospective Observational Study Methodology to Capture Economic Burden Evidence in a Rare Disease Using Non-Tuberculous Mycobacteria Infection as a Model

    Nov 1, 2015, 00:00

  • Italian Law 326/2003 for The Reimbursement of Orphan and Life Saving Drugs Awaiting Market Entry- Approvals, Rejections And Methods In Aifa’s Evaluation Process Between January 2013 And May 2015

    Nov 1, 2015, 00:00

  • The Trends In Orphan Drug Authorisation and Approval In Europe And In The United States - A Retrospective Study (2005-2014)

    Nov 1, 2015, 00:00

  • Anti-Dementia Medicine Dispensing Patterns- A Community Pharmacy Database Analysis

    Nov 1, 2015, 00:00

  • Bone Pain And Bone Targeting Agent (Bta) Treatment Patterns In Patients With Bone Metastases (Bms) From Breast Cancer (Bc) In Real World Setting In Europe

    Nov 1, 2015, 00:00

  • In Greece, During 2009-2014, Public Pharmaceutical Expenditure Undoubtedly Fell; But On Whose Backs?

    Nov 1, 2015, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85 (current)
  • 86
  • 87
  • 88
  • 89
  • 90
  • »